Cargando…

Vaccination against SARS-CoV-2 should be included in childhood vaccination programs

Detalles Bibliográficos
Autores principales:	Petersen, Eskild, Buchy, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084275/ https://www.ncbi.nlm.nih.gov/pubmed/33933590 http://dx.doi.org/10.1016/j.ijid.2021.04.082

Ejemplares similares

Should we vaccinate children against SARS-CoV-2?
por: The Lancet Infectious Diseases
Publicado: (2021)

SARS-CoV-2 vaccination should be required to practise medicine in Canada
por: McRae, Andrew D., et al.
Publicado: (2021)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

Impact of spike genetic variants in vaccines against SARS-CoV-2()
por: Reina, J., et al.
Publicado: (2021)

SARS-CoV-2 shedding and infectivity
por: Atkinson, Barry, et al.
Publicado: (2020)

In Pursuit of a SARS-CoV-2 Vaccine
por: Johnson, Alton R., et al.
Publicado: (2020)

SARS-CoV2 vaccines: Slow is fast
por: Green, Douglas R.
Publicado: (2020)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

SARS-CoV2 vaccine boosters for India
por: Kang, Gagandeep
Publicado: (2022)

The SARS-CoV-2 vaccines: Retrospective and perspectives
por: Epaulard, Olivier
Publicado: (2022)

Promising Extracellular Vesicle-Based Vaccines against Viruses, Including SARS-CoV-2
por: Sabanovic, Berina, et al.
Publicado: (2021)

A vaccine for SARS-CoV-2: goals and promises
Publicado: (2020)

Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021)

SARS-CoV-2 Vaccination for Children—An Open Issue
por: Caselli, Désirée, et al.
Publicado: (2021)

Vaccination for SARS-CoV-2 of migrants and refugees, Jordan
por: Bellizzi, Saverio, et al.
Publicado: (2021)

HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
por: Fleury, Herve
Publicado: (2022)

Influenza vaccination in the time of SARS-CoV-2()
por: Reina, Jordi
Publicado: (2021)

SARS-CoV-2 epidemiology and control, different scenarios for Turkey
por: PETERSEN, Eskild, et al.
Publicado: (2020)

Possible effect of the “original antigenic sin” in vaccination against new variants of SARS-CoV-2()
por: Reina, J.
Publicado: (2022)

A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals
por: Chavda, Vivek P, et al.
Publicado: (2021)

Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination
por: Chi, Xiangyang, et al.
Publicado: (2022)

Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines
por: Kremer, Eric J.
Publicado: (2020)

The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
por: Morris, Kevin V.
Publicado: (2020)

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2021)

Commentary on ‘Will vaccination refusal prolong the war on SARS-CoV-2?’
por: Welsby, Philip D
Publicado: (2020)

Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine
por: Matsuzaka, Yasunari, et al.
Publicado: (2023)

Advancing COVID-19 vaccines – avoiding different regulatory standards for different vaccines and need for open and transparent data sharing
por: Petersen, Eskild, et al.
Publicado: (2020)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Petersen, Eskild, et al.
Publicado: (2020)

The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2021)

Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021)

Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
por: Gómez, Carmen Elena, et al.
Publicado: (2021)

A booster shot of vaccine against SARS-CoV-2 should be rigorously promoted and implemented in China
por: Yin, Yong, et al.
Publicado: (2023)

Can an effective SARS-CoV-2 vaccine be developed for the older population?
por: Pawelec, Graham, et al.
Publicado: (2020)

Realising the potential of SARS-CoV-2 vaccines—a long shot?
por: The Lancet Respiratory Medicine
Publicado: (2021)

SARS-CoV-2/COVID-19 Vaccines: The Promises and the Challenges Ahead
por: Baldo, Vincenzo, et al.
Publicado: (2021)

SARS-CoV-2 Vaccination — An Ounce (Actually, Much Less) of Prevention
por: Rubin, Eric J., et al.
Publicado: (2020)

Editorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19
por: Parums, Dinah V.
Publicado: (2021)

SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?
por: Krueger, Karen M., et al.
Publicado: (2022)

Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer
por: Chebel, Roy, et al.
Publicado: (2021)

SARS-CoV-2 Vaccination: What Can We Expect Now?
por: Meurens, François, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9vgg12pq1b22ttsc5u3c9mrsld